Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Certified by Founder
Lodge
Baseimmune
start up
United Kingdom
- London, England
- 29/02/2024
- Series A
- $11,402,055
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
- Industry Biotechnology Research
- Website https://www.baseimmune.co.uk/
- LinkedIn https://www.linkedin.com/company/baseimmune/
Related People
Joshua BlightCo Founder
United Kingdom -
ND
Research scientist and biotech co-founder specialising in infectious diseases with a particular interest in mosquito-borne diseases. Skilled in Bioinformatics, Cell Biology, Vaccinology, Immunology, Parasitology and Molecular Biology. Additional experience in Science Communication, Public Engagement and Graphic Design. DPhil in Clinical Medicine, Oxford.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)